Stocks
Corcept Therapeutics Incorporated (CORT) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 16.2 | -3.78 | -3.40 | 34.9 | 47.5 | -1 230 | ||
| Changes by years, y/y, % | -18% | -123% | -10% | -1 127% | +36% | +19.2% | |||
Corcept Therapeutics Incorporated. EV/EBITDA
Corcept Therapeutics Incorporated. EV/EBITDA, changes, %
Corcept Therapeutics Incorporated (CORT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 97.6 | 67.1 | 105.7 | 52.2 | 286.3 | -1 230 | |
| Changes by years, y/y, % | -3 029% | -2 041% | +261% | +55% | +193% | |||
| Changes by quarters, q/q, % | +191% | -31% | +57% | -51% | +449% | |||
